Viral vector and plasmid DNA Market 2027 By Product, Applications | The Insight Partners

Viral vector and plasmid DNA Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Plasmid DNA, Viral Vector); Applications (Gene and Cancer therapies, Viral Infection, Immunotherapy, Others)

Report Code: TIPRE00015183 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Viral vectors are used to deliver a variety of toxic genes to tumor cells, taking advantage of tumor cells' altered properties to kill them selectively. Several types of viral vectors can be used to deliver nucleic acids into the genetic makeup of cells, including retrovirus, adenovirus, lentivirus, adeno-associated virus, and herpes simplex virus-each with its advantages and disadvantages for specific applications. The plasmid DNA is used in recombinant DNA technology and genetic engineering.
Plasmid DNA helps to survive the organism. It also kills other host cells by producing toxic proteins and protecting their cells by developing resistance or executing the foreign body. The plasmid also helps in replicating the bacterial DNA in some harsh conditions.

MARKET DYNAMICS

Factors driving the growth of the viral vector and plasmid DNA Market are the growing prevalence of cancer genetic disorders, and infectious diseases coupled with a rising number of clinical studies and availability of funding for gene therapy developments. Though, the high cost of gene therapies is projected to hamper the growth of the market. Moreover, the potential applications in novel drug delivery approaches are anticipated to drive the growth of the markets.

MARKET SCOPE

The "Viral vector and plasmid DNA Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of viral vector and plasmid DNA Market with detailed market segmentation by product and application. The Viral vector and plasmid DNA Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in viral vector and plasmid DNA Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Viral vector and plasmid DNA Market is segmented on the basis of product and application.
Based on product, the market is segmented as plasmid DNA and viral vector. On the basis of applications, the market is categorized as gene and cancer therapies, viral Infection, immunotherapy, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the viral vector and plasmid DNA Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Viral vector and plasmid DNA Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Viral vector and plasmid DNA Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the viral vector and plasmid DNA Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the viral vector and plasmid DNA Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from viral vector and plasmid DNA Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Viral Vector and Plasmid DNAin the global market. Below mentioned is the list of few companies engaged in the viral vector and plasmid DNA Market.

The report also includes the profiles of key players in viral vector and plasmid DNA Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Novasep
  •  Merck
  •  Cobra Biologics
  •  uniQure N.V.
  •  Waisman Biomanufacturing
  •  Creative Biogene
  •  The Cell and Gene Therapy Catapult
  •  Aldevron
  •  Addgene
  •  Brammer Bio
  •  Oxford BioMedica
  •  FinVector

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Viral Vector And Plasmid DNA Market - By Product
1.3.2 Viral Vector And Plasmid DNA Market - By Applications
1.3.3 Viral Vector And Plasmid DNA Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. VIRAL VECTOR AND PLASMID DNA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. VIRAL VECTOR AND PLASMID DNA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. VIRAL VECTOR AND PLASMID DNA MARKET - GLOBAL MARKET ANALYSIS
6.1. VIRAL VECTOR AND PLASMID DNA - GLOBAL MARKET OVERVIEW
6.2. VIRAL VECTOR AND PLASMID DNA - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. VIRAL VECTOR AND PLASMID DNA MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PLASMID DNA
7.3.1. Overview
7.3.2. Plasmid DNA Market Forecast and Analysis
7.4. VIRAL VECTOR
7.4.1. Overview
7.4.2. Viral Vector Market Forecast and Analysis
8. VIRAL VECTOR AND PLASMID DNA MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. GENE AND CANCER THERAPIES
8.3.1. Overview
8.3.2. Gene and Cancer therapies Market Forecast and Analysis
8.4. VIRAL INFECTION
8.4.1. Overview
8.4.2. Viral Infection Market Forecast and Analysis
8.5. IMMUNOTHERAPY
8.5.1. Overview
8.5.2. Immunotherapy Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. VIRAL VECTOR AND PLASMID DNA MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Viral Vector And Plasmid DNA Market Overview
9.1.2 North America Viral Vector And Plasmid DNA Market Forecasts and Analysis
9.1.3 North America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Product
9.1.4 North America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Applications
9.1.5 North America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Countries
9.1.5.1 United States Viral Vector And Plasmid DNA Market
9.1.5.1.1 United States Viral Vector And Plasmid DNA Market by Product
9.1.5.1.2 United States Viral Vector And Plasmid DNA Market by Applications
9.1.5.2 Canada Viral Vector And Plasmid DNA Market
9.1.5.2.1 Canada Viral Vector And Plasmid DNA Market by Product
9.1.5.2.2 Canada Viral Vector And Plasmid DNA Market by Applications
9.1.5.3 Mexico Viral Vector And Plasmid DNA Market
9.1.5.3.1 Mexico Viral Vector And Plasmid DNA Market by Product
9.1.5.3.2 Mexico Viral Vector And Plasmid DNA Market by Applications
9.1.5.4 US Viral Vector And Plasmid DNA Market
9.1.5.4.1 US Viral Vector And Plasmid DNA Market by Product
9.1.5.4.2 US Viral Vector And Plasmid DNA Market by Applications
9.2. EUROPE
9.2.1 Europe Viral Vector And Plasmid DNA Market Overview
9.2.2 Europe Viral Vector And Plasmid DNA Market Forecasts and Analysis
9.2.3 Europe Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Product
9.2.4 Europe Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Applications
9.2.5 Europe Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Viral Vector And Plasmid DNA Market
9.2.5.1.1 Germany Viral Vector And Plasmid DNA Market by Product
9.2.5.1.2 Germany Viral Vector And Plasmid DNA Market by Applications
9.2.5.2 France Viral Vector And Plasmid DNA Market
9.2.5.2.1 France Viral Vector And Plasmid DNA Market by Product
9.2.5.2.2 France Viral Vector And Plasmid DNA Market by Applications
9.2.5.3 Italy Viral Vector And Plasmid DNA Market
9.2.5.3.1 Italy Viral Vector And Plasmid DNA Market by Product
9.2.5.3.2 Italy Viral Vector And Plasmid DNA Market by Applications
9.2.5.4 Spain Viral Vector And Plasmid DNA Market
9.2.5.4.1 Spain Viral Vector And Plasmid DNA Market by Product
9.2.5.4.2 Spain Viral Vector And Plasmid DNA Market by Applications
9.2.5.5 United Kingdom Viral Vector And Plasmid DNA Market
9.2.5.5.1 United Kingdom Viral Vector And Plasmid DNA Market by Product
9.2.5.5.2 United Kingdom Viral Vector And Plasmid DNA Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Viral Vector And Plasmid DNA Market Overview
9.3.2 Asia-Pacific Viral Vector And Plasmid DNA Market Forecasts and Analysis
9.3.3 Asia-Pacific Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Viral Vector And Plasmid DNA Market
9.3.5.1.1 Australia Viral Vector And Plasmid DNA Market by Product
9.3.5.1.2 Australia Viral Vector And Plasmid DNA Market by Applications
9.3.5.2 China Viral Vector And Plasmid DNA Market
9.3.5.2.1 China Viral Vector And Plasmid DNA Market by Product
9.3.5.2.2 China Viral Vector And Plasmid DNA Market by Applications
9.3.5.3 India Viral Vector And Plasmid DNA Market
9.3.5.3.1 India Viral Vector And Plasmid DNA Market by Product
9.3.5.3.2 India Viral Vector And Plasmid DNA Market by Applications
9.3.5.4 Japan Viral Vector And Plasmid DNA Market
9.3.5.4.1 Japan Viral Vector And Plasmid DNA Market by Product
9.3.5.4.2 Japan Viral Vector And Plasmid DNA Market by Applications
9.3.5.5 South Korea Viral Vector And Plasmid DNA Market
9.3.5.5.1 South Korea Viral Vector And Plasmid DNA Market by Product
9.3.5.5.2 South Korea Viral Vector And Plasmid DNA Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Viral Vector And Plasmid DNA Market Overview
9.4.2 Middle East and Africa Viral Vector And Plasmid DNA Market Forecasts and Analysis
9.4.3 Middle East and Africa Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Viral Vector And Plasmid DNA Market
9.4.5.1.1 South Africa Viral Vector And Plasmid DNA Market by Product
9.4.5.1.2 South Africa Viral Vector And Plasmid DNA Market by Applications
9.4.5.2 Saudi Arabia Viral Vector And Plasmid DNA Market
9.4.5.2.1 Saudi Arabia Viral Vector And Plasmid DNA Market by Product
9.4.5.2.2 Saudi Arabia Viral Vector And Plasmid DNA Market by Applications
9.4.5.3 U.A.E Viral Vector And Plasmid DNA Market
9.4.5.3.1 U.A.E Viral Vector And Plasmid DNA Market by Product
9.4.5.3.2 U.A.E Viral Vector And Plasmid DNA Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Viral Vector And Plasmid DNA Market Overview
9.5.2 South and Central America Viral Vector And Plasmid DNA Market Forecasts and Analysis
9.5.3 South and Central America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Product
9.5.4 South and Central America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Viral Vector And Plasmid DNA Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Viral Vector And Plasmid DNA Market
9.5.5.1.1 Brazil Viral Vector And Plasmid DNA Market by Product
9.5.5.1.2 Brazil Viral Vector And Plasmid DNA Market by Applications
9.5.5.2 Argentina Viral Vector And Plasmid DNA Market
9.5.5.2.1 Argentina Viral Vector And Plasmid DNA Market by Product
9.5.5.2.2 Argentina Viral Vector And Plasmid DNA Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL VIRAL VECTOR AND PLASMID DNA MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. VIRAL VECTOR AND PLASMID DNA MARKET, KEY COMPANY PROFILES
12.1. NOVASEP
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. COBRA BIOLOGICS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. UNIQURE N.V.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. WAISMAN BIOMANUFACTURING
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CREATIVE BIOGENE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THE CELL AND GENE THERAPY CATAPULT
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ALDEVRON
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ADDGENE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BRAMMER BIO
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. OXFORD BIOMEDICA
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. FINVECTOR
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

The List of Companies

1. Novasep
2. Merck
3. Cobra Biologics
4. uniQure N.V.
5. Waisman Biomanufacturing
6. Creative Biogene
7. The Cell and Gene Therapy Catapult
8. Aldevron
9. Addgene
10. Brammer Bio
11. Oxford BioMedica
12. FinVector
TIPRE00015183
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking